ARC Launches HaMeirim: Sheba’s New Cardiovascular Innovation Center
Led by Prof. Ehud Ra’anani, Director of Leviev Cardiovascular and Thoracic Center at Sheba, and managed by Amir Lichter, Head of Innovation Center at ARC-Cardiovascular, HaMeirim, aims to ignite a new era of cardiovascular breakthroughs at Sheba by channeling integrated clinical innovation. Clinician-startup teams will co-develop data- and AI-driven medical devices guided by real-time feedback from active treatment environments, building on ARC’s proven model of success.
A Living Tribute to Gal and Eyal
HaMeirim operates from the new Heart Center building, featuring a memorial space at the entrance with work by Israel Prize laureate artist, Michal Rovner, to honor Gal Meir Izenkot Z”L and Eyal Meir Berkowitz Z”L, who both fell in the Iron Swords War. The name HaMeirim or “The Radiant Ones” expresses the essence these two young men embodied: light, purpose, and spirit. Mirrored in their shared middle name, Meir, this new space symbolizes an enduring commitment, an unwavering flame, to advance innovative work even in times of great darkness and pain.
The inauguration occurred thanks to Marius Nacht’s generous donation, held as a conference in Sourasky Hall. Family members participated, including Shmaya Berkowitz, Eyal Meir’s father and Gadi Eizenkot, Gal Meir’s father and former IDF Chief of Staff, who gave a personal onstage interview with Dana Weiss, journalist and anchorwoman of Channel 12 in Israel.
Advancing Sheba’s Vision of Clinical-Startup Collaboration
HaMeirim represents ARC Cardiovascular’s next chapter in turning collaboration into real-world impact. The new Heart, Thorax, and Vascular Center innovation hub will generate integrated clinical innovation through a shared workspace where clinical teams and startups jointly develop medical devices and technologies grounded in data and AI.
Working in an incubator setting with proximity to frontline care enables immediate clinical feedback, allowing ventures to refine solutions in real time and test them within active treatment environments. This model, already seen in successes like ARC’s AISAP, an FDA-approved platform that uses AI in ultrasound diagnostic technology, demonstrates how clinician‑startup partnerships can elevate patient outcomes and the quality of medicine worldwide.
Discover more about Sheba’s global innovations at sheba-global.com.
More Posts
Sheba’s Prof. Amitai Ziv Awarded by IMSH for Medical Simulation Excellence
Prof. Amitai Ziv, Founder of MSR-Azrieli Medical Simulation Center and Director of the Rehabilitation Hospital at Sheba Medical Center, has received...
Sheba’s Physicians Sweep Forbes Israel’s 2025 “Best Doctors” List
Forbes Israel has named an exceptional number of Sheba Medical Center’s physicians on its 2025 “Best Doctors” list. Earlier this year, Sheba was ranked by Newsweek as one of the World’s Top 10 Hospitals. This recognition and alignment between institutional and individual excellence signals to the global medical community that Sheba concentrates many of Israel’s most trusted clinical leaders under one roof.
Twinning and Training: Scalable Solutions for Global Eye Cancer Equity
Sheba Global Ophthalmology (SGO) demonstrates how sustainable twinning and hands-on training create self-reliant ocular oncology capacity in low- and middle-income countries (LMICs), far surpassing the limitations of short-term outreach.
